HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer.

AbstractBACKGROUND:
Oral mucositis (OM)-related pain affects most patients with head and neck cancer during treatments, but its management is not standardized.
METHODS:
We retrospectively collected data about the opioid therapy used for OM-induced pain in all patients with oropharyngeal cancer treated with chemoradiotherapy (CRT) between 2009 and 2013. To compare the different opioids, a conversion into oral morphine equivalent daily dose (OMEDD) was performed. The highest OMEDD (h-OMEDD) and the opioids' weekly increase were associated with patient, tumor, or treatment-related characteristics in order to identify predictive factors of opioid consumption.
RESULTS:
Ninety-seven percent of patients received opioids. The h-OMEDD was significantly correlated with a higher OM-grade and a lower smoking history. The weekly opioids' increase was higher in patients with lower smoking history and human papillomavirus (HPV) positivity.
CONCLUSION:
Opioid therapy remains the mainstay for OM-related pain management during CRT. The role of previous smoking and HPV on opioid use needs further confirmations. © 2016 Wiley Periodicals, Inc. Head Neck 38: E1521-E1527, 2016.
AuthorsSalvatore Alfieri, Carla I Ripamonti, Sara Marceglia, Ester Orlandi, Nicola A Iacovelli, Roberta Granata, Anna Cavallo, Paolo Pozzi, Roberto Boffi, Cristiana Bergamini, Martina Imbimbo, Laura Pala, Carlo Resteghini, Aurora Mirabile, Laura D Locati, Lisa Licitra, Paolo Bossi
JournalHead & neck (Head Neck) Vol. 38 Suppl 1 Pg. E1521-7 (04 2016) ISSN: 1097-0347 [Electronic] United States
PMID26849016 (Publication Type: Journal Article)
Copyright© 2016 Wiley Periodicals, Inc.
Chemical References
  • Analgesics
  • Analgesics, Opioid
Topics
  • Adult
  • Aged
  • Analgesics (administration & dosage, therapeutic use)
  • Analgesics, Opioid (administration & dosage, therapeutic use)
  • Chemoradiotherapy (adverse effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mucositis (chemically induced)
  • Oropharyngeal Neoplasms (therapy)
  • Smoking

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: